Status:
RECRUITING
EUmetriosis: Insights Into the Pathogenesis of Endometriosis
Lead Sponsor:
Université Catholique de Louvain
Conditions:
Endometriosis
Eligibility:
FEMALE
18-56 years
Phase:
NA
Brief Summary
This study investigates epigenetic changes in menstrual effluent and plasma from women with endometriosis to identify potential non-invasive diagnostic biomarkers for the disease.
Eligibility Criteria
Inclusion
- Premenopausal
- In spontaneous menstrual cycle (no hormonal treatments for the last 3 months)
- Healthy or with a clear diagnosis of endometriosis via ultrasound, MRI or laparoscopy
Exclusion
- HIV or Hepatitis positive
- Pregnancy
Key Trial Info
Start Date :
May 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07000786
Start Date
May 12 2025
End Date
December 31 2029
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques universitaires Saint-Luc
Brussels, Belgium, 1200